nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—PLG—vein—testicular cancer	0.248	0.604	CbGeAlD
Tranexamic Acid—PLG—embryo—testicular cancer	0.047	0.114	CbGeAlD
Tranexamic Acid—PLG—gonad—testicular cancer	0.0319	0.0776	CbGeAlD
Tranexamic Acid—PLG—female gonad—testicular cancer	0.0259	0.063	CbGeAlD
Tranexamic Acid—PLG—testis—testicular cancer	0.023	0.0559	CbGeAlD
Tranexamic Acid—SLC15A2—seminal vesicle—testicular cancer	0.0141	0.0343	CbGeAlD
Tranexamic Acid—SLC15A2—female gonad—testicular cancer	0.00829	0.0202	CbGeAlD
Tranexamic Acid—SLC15A2—testis—testicular cancer	0.00735	0.0179	CbGeAlD
Tranexamic Acid—SLC15A2—lymph node—testicular cancer	0.00533	0.013	CbGeAlD
Tranexamic Acid—Musculoskeletal pain—Doxorubicin—testicular cancer	0.00165	0.0028	CcSEcCtD
Tranexamic Acid—Pulmonary embolism—Doxorubicin—testicular cancer	0.00163	0.00277	CcSEcCtD
Tranexamic Acid—Ventricular tachycardia—Doxorubicin—testicular cancer	0.00163	0.00277	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Vinblastine—testicular cancer	0.00162	0.00275	CcSEcCtD
Tranexamic Acid—Myalgia—Dactinomycin—testicular cancer	0.00162	0.00274	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Ifosfamide—testicular cancer	0.00161	0.00274	CcSEcCtD
Tranexamic Acid—Eye disorder—Cisplatin—testicular cancer	0.00161	0.00273	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Vinblastine—testicular cancer	0.00161	0.00273	CcSEcCtD
Tranexamic Acid—Anaemia—Ifosfamide—testicular cancer	0.00161	0.00273	CcSEcCtD
Tranexamic Acid—Flushing—Cisplatin—testicular cancer	0.0016	0.00271	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Cisplatin—testicular cancer	0.0016	0.00271	CcSEcCtD
Tranexamic Acid—Discomfort—Dactinomycin—testicular cancer	0.0016	0.00271	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Chlorambucil—testicular cancer	0.00158	0.00268	CcSEcCtD
Tranexamic Acid—Malaise—Ifosfamide—testicular cancer	0.00157	0.00266	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Epirubicin—testicular cancer	0.00157	0.00266	CcSEcCtD
Tranexamic Acid—Polyuria—Methotrexate—testicular cancer	0.00156	0.00264	CcSEcCtD
Tranexamic Acid—Immune system disorder—Cisplatin—testicular cancer	0.00156	0.00264	CcSEcCtD
Tranexamic Acid—Abdominal pain—Vinblastine—testicular cancer	0.00155	0.00264	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Cisplatin—testicular cancer	0.00155	0.00264	CcSEcCtD
Tranexamic Acid—Hypotension—Bleomycin—testicular cancer	0.00155	0.00263	CcSEcCtD
Tranexamic Acid—Asthenia—Chlorambucil—testicular cancer	0.00154	0.00261	CcSEcCtD
Tranexamic Acid—Arrhythmia—Cisplatin—testicular cancer	0.00154	0.00261	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00151	0.00257	CcSEcCtD
Tranexamic Acid—Convulsion—Ifosfamide—testicular cancer	0.00151	0.00256	CcSEcCtD
Tranexamic Acid—Dyspnoea—Bleomycin—testicular cancer	0.00148	0.00251	CcSEcCtD
Tranexamic Acid—Chest pain—Ifosfamide—testicular cancer	0.00148	0.00251	CcSEcCtD
Tranexamic Acid—Myalgia—Ifosfamide—testicular cancer	0.00148	0.00251	CcSEcCtD
Tranexamic Acid—Arthralgia—Ifosfamide—testicular cancer	0.00148	0.00251	CcSEcCtD
Tranexamic Acid—Eye disorder—Etoposide—testicular cancer	0.00147	0.0025	CcSEcCtD
Tranexamic Acid—Diarrhoea—Chlorambucil—testicular cancer	0.00147	0.00249	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Etoposide—testicular cancer	0.00146	0.00249	CcSEcCtD
Tranexamic Acid—Flushing—Etoposide—testicular cancer	0.00146	0.00249	CcSEcCtD
Tranexamic Acid—Discomfort—Ifosfamide—testicular cancer	0.00146	0.00248	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Doxorubicin—testicular cancer	0.00145	0.00246	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Vinblastine—testicular cancer	0.00145	0.00246	CcSEcCtD
Tranexamic Acid—Visual disturbance—Methotrexate—testicular cancer	0.00144	0.00245	CcSEcCtD
Tranexamic Acid—Muscle spasms—Cisplatin—testicular cancer	0.00144	0.00245	CcSEcCtD
Tranexamic Acid—Angiopathy—Etoposide—testicular cancer	0.00143	0.00243	CcSEcCtD
Tranexamic Acid—Immune system disorder—Etoposide—testicular cancer	0.00142	0.00242	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Etoposide—testicular cancer	0.00142	0.00241	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Ifosfamide—testicular cancer	0.00142	0.00241	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00141	0.0024	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00141	0.0024	CcSEcCtD
Tranexamic Acid—Asthenia—Vinblastine—testicular cancer	0.00141	0.0024	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Methotrexate—testicular cancer	0.00139	0.00237	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Ifosfamide—testicular cancer	0.00139	0.00236	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Cisplatin—testicular cancer	0.00139	0.00236	CcSEcCtD
Tranexamic Acid—Anaemia—Cisplatin—testicular cancer	0.00139	0.00235	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Bleomycin—testicular cancer	0.00137	0.00232	CcSEcCtD
Tranexamic Acid—Vomiting—Chlorambucil—testicular cancer	0.00136	0.00232	CcSEcCtD
Tranexamic Acid—Malaise—Cisplatin—testicular cancer	0.00135	0.0023	CcSEcCtD
Tranexamic Acid—Diarrhoea—Vinblastine—testicular cancer	0.00135	0.00228	CcSEcCtD
Tranexamic Acid—Fatigue—Dactinomycin—testicular cancer	0.00134	0.00227	CcSEcCtD
Tranexamic Acid—Back pain—Etoposide—testicular cancer	0.00133	0.00226	CcSEcCtD
Tranexamic Acid—Hypotension—Ifosfamide—testicular cancer	0.00133	0.00225	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00132	0.00224	CcSEcCtD
Tranexamic Acid—Muscle spasms—Etoposide—testicular cancer	0.00132	0.00224	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Epirubicin—testicular cancer	0.0013	0.00222	CcSEcCtD
Tranexamic Acid—Dizziness—Vinblastine—testicular cancer	0.0013	0.00221	CcSEcCtD
Tranexamic Acid—Convulsion—Cisplatin—testicular cancer	0.0013	0.00221	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00129	0.0022	CcSEcCtD
Tranexamic Acid—Myalgia—Cisplatin—testicular cancer	0.00128	0.00217	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Dactinomycin—testicular cancer	0.00128	0.00217	CcSEcCtD
Tranexamic Acid—Nausea—Chlorambucil—testicular cancer	0.00127	0.00216	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Etoposide—testicular cancer	0.00127	0.00216	CcSEcCtD
Tranexamic Acid—Anaemia—Etoposide—testicular cancer	0.00127	0.00216	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00127	0.00215	CcSEcCtD
Tranexamic Acid—Dyspnoea—Ifosfamide—testicular cancer	0.00127	0.00215	CcSEcCtD
Tranexamic Acid—Discomfort—Cisplatin—testicular cancer	0.00126	0.00214	CcSEcCtD
Tranexamic Acid—Migraine—Epirubicin—testicular cancer	0.00126	0.00214	CcSEcCtD
Tranexamic Acid—Vomiting—Vinblastine—testicular cancer	0.00125	0.00212	CcSEcCtD
Tranexamic Acid—Malaise—Etoposide—testicular cancer	0.00124	0.0021	CcSEcCtD
Tranexamic Acid—Headache—Vinblastine—testicular cancer	0.00123	0.00209	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00123	0.00208	CcSEcCtD
Tranexamic Acid—Abdominal pain—Dactinomycin—testicular cancer	0.00122	0.00208	CcSEcCtD
Tranexamic Acid—Fatigue—Ifosfamide—testicular cancer	0.00122	0.00208	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Cisplatin—testicular cancer	0.00122	0.00208	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Bleomycin—testicular cancer	0.00122	0.00208	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00122	0.00208	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Etoposide—testicular cancer	0.00121	0.00205	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Doxorubicin—testicular cancer	0.00121	0.00205	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Cisplatin—testicular cancer	0.0012	0.00204	CcSEcCtD
Tranexamic Acid—Asthenia—Bleomycin—testicular cancer	0.00119	0.00202	CcSEcCtD
Tranexamic Acid—Convulsion—Etoposide—testicular cancer	0.00119	0.00202	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Ifosfamide—testicular cancer	0.00117	0.00199	CcSEcCtD
Tranexamic Acid—Chest pain—Etoposide—testicular cancer	0.00117	0.00199	CcSEcCtD
Tranexamic Acid—Nausea—Vinblastine—testicular cancer	0.00117	0.00198	CcSEcCtD
Tranexamic Acid—Migraine—Doxorubicin—testicular cancer	0.00116	0.00198	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00116	0.00197	CcSEcCtD
Tranexamic Acid—Discomfort—Etoposide—testicular cancer	0.00116	0.00196	CcSEcCtD
Tranexamic Acid—Hypotension—Cisplatin—testicular cancer	0.00114	0.00194	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Dactinomycin—testicular cancer	0.00114	0.00194	CcSEcCtD
Tranexamic Acid—Abdominal discomfort—Methotrexate—testicular cancer	0.00113	0.00192	CcSEcCtD
Tranexamic Acid—Abdominal pain—Ifosfamide—testicular cancer	0.00112	0.0019	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Etoposide—testicular cancer	0.00112	0.0019	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00111	0.00189	CcSEcCtD
Tranexamic Acid—Asthenia—Dactinomycin—testicular cancer	0.00111	0.00189	CcSEcCtD
Tranexamic Acid—Dyspnoea—Cisplatin—testicular cancer	0.00109	0.00185	CcSEcCtD
Tranexamic Acid—Angina pectoris—Epirubicin—testicular cancer	0.00108	0.00183	CcSEcCtD
Tranexamic Acid—Diarrhoea—Dactinomycin—testicular cancer	0.00106	0.0018	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00106	0.00179	CcSEcCtD
Tranexamic Acid—Vomiting—Bleomycin—testicular cancer	0.00106	0.00179	CcSEcCtD
Tranexamic Acid—Hypotension—Etoposide—testicular cancer	0.00105	0.00178	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Ifosfamide—testicular cancer	0.00105	0.00178	CcSEcCtD
Tranexamic Acid—Renal failure—Methotrexate—testicular cancer	0.00103	0.00176	CcSEcCtD
Tranexamic Acid—Asthenia—Ifosfamide—testicular cancer	0.00102	0.00173	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Cisplatin—testicular cancer	0.00101	0.00171	CcSEcCtD
Tranexamic Acid—Dyspnoea—Etoposide—testicular cancer	0.000999	0.0017	CcSEcCtD
Tranexamic Acid—Angina pectoris—Doxorubicin—testicular cancer	0.000996	0.00169	CcSEcCtD
Tranexamic Acid—Nausea—Bleomycin—testicular cancer	0.000986	0.00167	CcSEcCtD
Tranexamic Acid—Vomiting—Dactinomycin—testicular cancer	0.000985	0.00167	CcSEcCtD
Tranexamic Acid—Diarrhoea—Ifosfamide—testicular cancer	0.000971	0.00165	CcSEcCtD
Tranexamic Acid—Renal failure—Epirubicin—testicular cancer	0.000968	0.00164	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Etoposide—testicular cancer	0.000968	0.00164	CcSEcCtD
Tranexamic Acid—Fatigue—Etoposide—testicular cancer	0.000966	0.00164	CcSEcCtD
Tranexamic Acid—Haemoglobin—Methotrexate—testicular cancer	0.00095	0.00161	CcSEcCtD
Tranexamic Acid—Haemorrhage—Methotrexate—testicular cancer	0.000945	0.0016	CcSEcCtD
Tranexamic Acid—Dizziness—Ifosfamide—testicular cancer	0.000938	0.00159	CcSEcCtD
Tranexamic Acid—Sinusitis—Epirubicin—testicular cancer	0.000924	0.00157	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Etoposide—testicular cancer	0.000924	0.00157	CcSEcCtD
Tranexamic Acid—Nausea—Dactinomycin—testicular cancer	0.00092	0.00156	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Etoposide—testicular cancer	0.000916	0.00156	CcSEcCtD
Tranexamic Acid—Visual impairment—Methotrexate—testicular cancer	0.000911	0.00155	CcSEcCtD
Tranexamic Acid—Vomiting—Ifosfamide—testicular cancer	0.000902	0.00153	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Cisplatin—testicular cancer	0.000901	0.00153	CcSEcCtD
Tranexamic Acid—Renal failure—Doxorubicin—testicular cancer	0.000896	0.00152	CcSEcCtD
Tranexamic Acid—Haemoglobin—Epirubicin—testicular cancer	0.000889	0.00151	CcSEcCtD
Tranexamic Acid—Abdominal pain—Etoposide—testicular cancer	0.000886	0.0015	CcSEcCtD
Tranexamic Acid—Haemorrhage—Epirubicin—testicular cancer	0.000884	0.0015	CcSEcCtD
Tranexamic Acid—Eye disorder—Methotrexate—testicular cancer	0.000883	0.0015	CcSEcCtD
Tranexamic Acid—Asthenia—Cisplatin—testicular cancer	0.000878	0.00149	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Methotrexate—testicular cancer	0.000877	0.00149	CcSEcCtD
Tranexamic Acid—Angiopathy—Methotrexate—testicular cancer	0.000857	0.00146	CcSEcCtD
Tranexamic Acid—Sinusitis—Doxorubicin—testicular cancer	0.000855	0.00145	CcSEcCtD
Tranexamic Acid—Immune system disorder—Methotrexate—testicular cancer	0.000854	0.00145	CcSEcCtD
Tranexamic Acid—Visual impairment—Epirubicin—testicular cancer	0.000852	0.00145	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Methotrexate—testicular cancer	0.000852	0.00145	CcSEcCtD
Tranexamic Acid—Nausea—Ifosfamide—testicular cancer	0.000843	0.00143	CcSEcCtD
Tranexamic Acid—Diarrhoea—Cisplatin—testicular cancer	0.000837	0.00142	CcSEcCtD
Tranexamic Acid—Eye disorder—Epirubicin—testicular cancer	0.000826	0.0014	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Etoposide—testicular cancer	0.000826	0.0014	CcSEcCtD
Tranexamic Acid—Haemoglobin—Doxorubicin—testicular cancer	0.000822	0.0014	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Epirubicin—testicular cancer	0.000821	0.00139	CcSEcCtD
Tranexamic Acid—Flushing—Epirubicin—testicular cancer	0.000821	0.00139	CcSEcCtD
Tranexamic Acid—Haemorrhage—Doxorubicin—testicular cancer	0.000818	0.00139	CcSEcCtD
Tranexamic Acid—Asthenia—Etoposide—testicular cancer	0.000804	0.00137	CcSEcCtD
Tranexamic Acid—Angiopathy—Epirubicin—testicular cancer	0.000802	0.00136	CcSEcCtD
Tranexamic Acid—Immune system disorder—Epirubicin—testicular cancer	0.000799	0.00136	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Epirubicin—testicular cancer	0.000797	0.00135	CcSEcCtD
Tranexamic Acid—Back pain—Methotrexate—testicular cancer	0.000796	0.00135	CcSEcCtD
Tranexamic Acid—Arrhythmia—Epirubicin—testicular cancer	0.00079	0.00134	CcSEcCtD
Tranexamic Acid—Visual impairment—Doxorubicin—testicular cancer	0.000789	0.00134	CcSEcCtD
Tranexamic Acid—Vomiting—Cisplatin—testicular cancer	0.000778	0.00132	CcSEcCtD
Tranexamic Acid—Diarrhoea—Etoposide—testicular cancer	0.000767	0.0013	CcSEcCtD
Tranexamic Acid—Eye disorder—Doxorubicin—testicular cancer	0.000765	0.0013	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Methotrexate—testicular cancer	0.000763	0.0013	CcSEcCtD
Tranexamic Acid—Anaemia—Methotrexate—testicular cancer	0.00076	0.00129	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Doxorubicin—testicular cancer	0.000759	0.00129	CcSEcCtD
Tranexamic Acid—Flushing—Doxorubicin—testicular cancer	0.000759	0.00129	CcSEcCtD
Tranexamic Acid—Back pain—Epirubicin—testicular cancer	0.000745	0.00126	CcSEcCtD
Tranexamic Acid—Angiopathy—Doxorubicin—testicular cancer	0.000742	0.00126	CcSEcCtD
Tranexamic Acid—Malaise—Methotrexate—testicular cancer	0.000742	0.00126	CcSEcCtD
Tranexamic Acid—Dizziness—Etoposide—testicular cancer	0.000741	0.00126	CcSEcCtD
Tranexamic Acid—Muscle spasms—Epirubicin—testicular cancer	0.00074	0.00126	CcSEcCtD
Tranexamic Acid—Immune system disorder—Doxorubicin—testicular cancer	0.000739	0.00126	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Doxorubicin—testicular cancer	0.000737	0.00125	CcSEcCtD
Tranexamic Acid—Arrhythmia—Doxorubicin—testicular cancer	0.000731	0.00124	CcSEcCtD
Tranexamic Acid—Nausea—Cisplatin—testicular cancer	0.000727	0.00123	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Epirubicin—testicular cancer	0.000714	0.00121	CcSEcCtD
Tranexamic Acid—Convulsion—Methotrexate—testicular cancer	0.000713	0.00121	CcSEcCtD
Tranexamic Acid—Vomiting—Etoposide—testicular cancer	0.000713	0.00121	CcSEcCtD
Tranexamic Acid—Anaemia—Epirubicin—testicular cancer	0.000711	0.00121	CcSEcCtD
Tranexamic Acid—Headache—Etoposide—testicular cancer	0.000702	0.00119	CcSEcCtD
Tranexamic Acid—Chest pain—Methotrexate—testicular cancer	0.0007	0.00119	CcSEcCtD
Tranexamic Acid—Arthralgia—Methotrexate—testicular cancer	0.0007	0.00119	CcSEcCtD
Tranexamic Acid—Myalgia—Methotrexate—testicular cancer	0.0007	0.00119	CcSEcCtD
Tranexamic Acid—Malaise—Epirubicin—testicular cancer	0.000694	0.00118	CcSEcCtD
Tranexamic Acid—Discomfort—Methotrexate—testicular cancer	0.000692	0.00117	CcSEcCtD
Tranexamic Acid—Back pain—Doxorubicin—testicular cancer	0.000689	0.00117	CcSEcCtD
Tranexamic Acid—Muscle spasms—Doxorubicin—testicular cancer	0.000685	0.00116	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Epirubicin—testicular cancer	0.000677	0.00115	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Methotrexate—testicular cancer	0.000671	0.00114	CcSEcCtD
Tranexamic Acid—Convulsion—Epirubicin—testicular cancer	0.000667	0.00113	CcSEcCtD
Tranexamic Acid—Nausea—Etoposide—testicular cancer	0.000666	0.00113	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Doxorubicin—testicular cancer	0.000661	0.00112	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Methotrexate—testicular cancer	0.000658	0.00112	CcSEcCtD
Tranexamic Acid—Anaemia—Doxorubicin—testicular cancer	0.000658	0.00112	CcSEcCtD
Tranexamic Acid—Chest pain—Epirubicin—testicular cancer	0.000655	0.00111	CcSEcCtD
Tranexamic Acid—Myalgia—Epirubicin—testicular cancer	0.000655	0.00111	CcSEcCtD
Tranexamic Acid—Arthralgia—Epirubicin—testicular cancer	0.000655	0.00111	CcSEcCtD
Tranexamic Acid—Discomfort—Epirubicin—testicular cancer	0.000648	0.0011	CcSEcCtD
Tranexamic Acid—Malaise—Doxorubicin—testicular cancer	0.000642	0.00109	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Epirubicin—testicular cancer	0.000628	0.00107	CcSEcCtD
Tranexamic Acid—Hypotension—Methotrexate—testicular cancer	0.000627	0.00107	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Doxorubicin—testicular cancer	0.000626	0.00106	CcSEcCtD
Tranexamic Acid—Convulsion—Doxorubicin—testicular cancer	0.000617	0.00105	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Epirubicin—testicular cancer	0.000616	0.00105	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000612	0.00104	CcSEcCtD
Tranexamic Acid—Chest pain—Doxorubicin—testicular cancer	0.000606	0.00103	CcSEcCtD
Tranexamic Acid—Myalgia—Doxorubicin—testicular cancer	0.000606	0.00103	CcSEcCtD
Tranexamic Acid—Arthralgia—Doxorubicin—testicular cancer	0.000606	0.00103	CcSEcCtD
Tranexamic Acid—Discomfort—Doxorubicin—testicular cancer	0.000599	0.00102	CcSEcCtD
Tranexamic Acid—Dyspnoea—Methotrexate—testicular cancer	0.000599	0.00102	CcSEcCtD
Tranexamic Acid—Dyspepsia—Methotrexate—testicular cancer	0.000591	0.001	CcSEcCtD
Tranexamic Acid—Hypotension—Epirubicin—testicular cancer	0.000587	0.000997	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Doxorubicin—testicular cancer	0.000581	0.000987	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00058	0.000984	CcSEcCtD
Tranexamic Acid—Fatigue—Methotrexate—testicular cancer	0.000579	0.000983	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000572	0.000972	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Doxorubicin—testicular cancer	0.00057	0.000968	CcSEcCtD
Tranexamic Acid—Dyspnoea—Epirubicin—testicular cancer	0.00056	0.000951	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Methotrexate—testicular cancer	0.000553	0.000939	CcSEcCtD
Tranexamic Acid—Dyspepsia—Epirubicin—testicular cancer	0.000553	0.000939	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Methotrexate—testicular cancer	0.000549	0.000932	CcSEcCtD
Tranexamic Acid—Hypotension—Doxorubicin—testicular cancer	0.000543	0.000922	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000542	0.000921	CcSEcCtD
Tranexamic Acid—Fatigue—Epirubicin—testicular cancer	0.000542	0.00092	CcSEcCtD
Tranexamic Acid—Abdominal pain—Methotrexate—testicular cancer	0.000531	0.000901	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00053	0.000899	CcSEcCtD
Tranexamic Acid—Dyspnoea—Doxorubicin—testicular cancer	0.000518	0.00088	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Epirubicin—testicular cancer	0.000518	0.000879	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Epirubicin—testicular cancer	0.000514	0.000872	CcSEcCtD
Tranexamic Acid—Dyspepsia—Doxorubicin—testicular cancer	0.000512	0.000869	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000502	0.000852	CcSEcCtD
Tranexamic Acid—Fatigue—Doxorubicin—testicular cancer	0.000501	0.000851	CcSEcCtD
Tranexamic Acid—Abdominal pain—Epirubicin—testicular cancer	0.000497	0.000843	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Methotrexate—testicular cancer	0.000495	0.00084	CcSEcCtD
Tranexamic Acid—Asthenia—Methotrexate—testicular cancer	0.000482	0.000818	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Doxorubicin—testicular cancer	0.000479	0.000813	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000475	0.000807	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Epirubicin—testicular cancer	0.000463	0.000786	CcSEcCtD
Tranexamic Acid—Abdominal pain—Doxorubicin—testicular cancer	0.00046	0.00078	CcSEcCtD
Tranexamic Acid—Diarrhoea—Methotrexate—testicular cancer	0.000459	0.00078	CcSEcCtD
Tranexamic Acid—Asthenia—Epirubicin—testicular cancer	0.000451	0.000765	CcSEcCtD
Tranexamic Acid—Dizziness—Methotrexate—testicular cancer	0.000444	0.000754	CcSEcCtD
Tranexamic Acid—Diarrhoea—Epirubicin—testicular cancer	0.00043	0.00073	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Doxorubicin—testicular cancer	0.000428	0.000727	CcSEcCtD
Tranexamic Acid—Vomiting—Methotrexate—testicular cancer	0.000427	0.000725	CcSEcCtD
Tranexamic Acid—Headache—Methotrexate—testicular cancer	0.000421	0.000714	CcSEcCtD
Tranexamic Acid—Asthenia—Doxorubicin—testicular cancer	0.000417	0.000708	CcSEcCtD
Tranexamic Acid—Dizziness—Epirubicin—testicular cancer	0.000415	0.000705	CcSEcCtD
Tranexamic Acid—Vomiting—Epirubicin—testicular cancer	0.000399	0.000678	CcSEcCtD
Tranexamic Acid—Nausea—Methotrexate—testicular cancer	0.000399	0.000677	CcSEcCtD
Tranexamic Acid—Diarrhoea—Doxorubicin—testicular cancer	0.000398	0.000675	CcSEcCtD
Tranexamic Acid—Headache—Epirubicin—testicular cancer	0.000394	0.000668	CcSEcCtD
Tranexamic Acid—Dizziness—Doxorubicin—testicular cancer	0.000384	0.000653	CcSEcCtD
Tranexamic Acid—Nausea—Epirubicin—testicular cancer	0.000373	0.000634	CcSEcCtD
Tranexamic Acid—Vomiting—Doxorubicin—testicular cancer	0.00037	0.000628	CcSEcCtD
Tranexamic Acid—Headache—Doxorubicin—testicular cancer	0.000364	0.000618	CcSEcCtD
Tranexamic Acid—Nausea—Doxorubicin—testicular cancer	0.000345	0.000586	CcSEcCtD
